Univest
Univest
  • Markets

Morepen Laboratories (MOREPENLAB) Share Price Falls 5.31% as Mid Cap Pharma Stock Tracks Lower

  • September 15, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Morepen Laboratories Share Price
Morepen Laboratories (MOREPENLAB) share price fell to Rs 139 today, down 5.31% from the previous close. Market cap was Rs 7,876.83 crore.

Morepen Laboratories Share Price fell to Rs 139.00 today, down 5.31% from the previous close of Rs 146.80, while the company’s market capitalisation stood at Rs 7,876.83 Cr. Morepen Laboratories Share Price Today is drawing attention because the move came within an intraday range of Rs 138.00 to Rs 148.25, after the stock opened at Rs 148.15. According to latest Univest figures, the decline is relevant not because of a stated company-specific trigger, but because the stock is trading as a Mid Cap name with a valuation that remains meaningfully above the broader healthcare benchmark. Morepen Laboratories Share Price is therefore a price-action story first, and a fundamentals-and-peer-comparison story second. The price move is confirmed in Univest data; a company-specific reason has not been established.

Morepen Laboratories Share Price is also important for investors tracking Morepen Laboratories Stock News, Morepen Laboratories Share Price News and Morepen Laboratories Share Price Update together, because the move sits inside a live trading session and should be read with the day’s range, valuation and sector context in view.

Table of Contents

Toggle
  • Morepen Laboratories (MOREPENLAB) Share Price Today: Price Action Analysis
  • Morepen Laboratories (MOREPENLAB) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Morepen Laboratories
  • About Morepen Laboratories
  • Track Morepen Laboratories Share Price on Univest
  • Frequently Asked Questions
    • Why did Morepen Laboratories Share Price fall today?
    • What is the current Morepen Laboratories Share Price?
    • How much did Morepen Laboratories Share Price decline today?
    • What is Morepen Laboratories market capitalisation?
    • How does Morepen Laboratories Share Price compare with sector valuation?
    • What do ROE and ROCE show for Morepen Laboratories?
    • What do EPS and book value mean for Morepen Laboratories Share Price?
    • Is dividend yield important for Morepen Laboratories?
    • Which peers are useful for Morepen Laboratories Share Price comparison?

Morepen Laboratories (MOREPENLAB) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 139
Previous Close Rs 146.8
Today's Move -Rs 7.80 (-5.31%)
Open Rs 148.15
High Rs 148.25
Low Rs 138
Market Capitalisation Rs 7,876.83 crore
Market Cap Category Mid Cap

Morepen Laboratories Share Price Today shows a clear intraday decline: the stock last traded at Rs 139.00, compared with the previous close of Rs 146.80, which means a fall of Rs 7.80 or 5.31%. Morepen Laboratories Share Price also moved between Rs 148.25 and Rs 138.00 during the session, after opening at Rs 148.15. That means the stock is trading near the lower end of its intraday band after first trading above the previous close. Morepen Laboratories Share Price sits in the Mid Cap category, with market capitalisation of Rs 7,876.83 Cr. For readers following Morepen Laboratories Stock Performance or Morepen Laboratories Share Price Live, the key factual point is simple: the decline is confirmed, the session remains open, and the move is large enough to place Morepen Laboratories Share Price among the more notable healthcare declines of the day. The next layer is whether fundamentals justify the current valuation in the context of the business.

Morepen Laboratories (MOREPENLAB) Fundamental Analysis

Metric Value
Market Capitalisation Rs 7,876.83 crore
P/E Ratio 57.24x
P/B Ratio 6.17x
ROE 7.96%
ROCE 10.19%
EPS Rs 2.56
Book Value Per Share Rs 23.78
Dividend Yield 0.14%

Morepen Laboratories (MOREPENLAB) fundamental metrics show P/E 57.24x, P/B 6.17x, ROE 7.96%, ROCE 10.19%. These ratios show where the company stands today and are not a call to buy or sell.

Morepen Laboratories has a market capitalisation of Rs 7,876.83 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 57.24x, P/B at 6.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.96% and ROCE of 10.19%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.14%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 57.24x
Benchmark Median P/E 31.87x
Benchmark Average P/E 48.48x
Benchmark P/E Range 3.58x to 708.87x
Company P/B Ratio 6.17x
Benchmark Median P/B 2.98x
Benchmark Average P/B 4.31x
Company ROE 7.96%
Benchmark Median ROE 11.61%
Benchmark Average ROE 10.59%
Company ROCE 10.19%
Benchmark Median ROCE 13.46%
Benchmark Average ROCE 13.36%
Company Market Capitalisation Rs 7,876.83 crore
Benchmark Median Market Cap Rs 854.81 crore
Benchmark Average Market Cap Rs 14,121.7 crore

Morepen Laboratories (MOREPENLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Morepen Laboratories (MOREPENLAB) has a P/E ratio of 57.24x, which is above the benchmark median of 31.87x, a difference of +79.6%. A P/E difference of this kind is a reference point rather than a recommendation.

Morepen Laboratories (MOREPENLAB) has a ROE of 7.96%, which is below the benchmark median of 11.61%, a difference of -31.44%. Morepen Laboratories (MOREPENLAB) has a ROCE of 10.19%, which is below the benchmark median of 13.46%, a difference of -24.29%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries SUNPHARMA 4,32,120.23 35.37 4.95 14.85 19.11
Divi's Laboratories DIVISLAB 2,53,389.76 86.95 14.4 16.19 21.51
Torrent Pharmaceuticals TORNTPHARM 1,81,739.76 82.14 19.96 26.76 19.27
Zydus Lifesciences ZYDUSLIFE 1,15,710.44 25.51 4.27 19.69 21.39
Laurus Labs LAURUSLABS 1,10,980.13 101.55 19.69 18.31 18.2

Morepen Laboratories (MOREPENLAB) has a P/E ratio of 57.24x compared with the displayed peer median of 82.14x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.96% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 10.19% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Morepen Laboratories (MOREPENLAB) has a market capitalisation of Rs 7,876.83 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Morepen Laboratories

  • Morepen Laboratories Share Price fell 5.31% in live trade and moved from Rs 146.80 to Rs 139.00.
  • Morepen Laboratories Share Price is trading within an intraday range of Rs 138.00 to Rs 148.25.
  • Morepen Laboratories Share Price carries a P/E of 57.24 and P/B of 6.17, both above the same-industry median.
  • Morepen Laboratories Share Price has ROE of 7.96% and ROCE of 10.19%, which sit below benchmark medians.
  • Morepen Laboratories Share Price remains a Mid Cap healthcare stock with market cap of Rs 7,876.83 Cr.

About Morepen Laboratories

Morepen Laboratories operates in Healthcare and the Pharmaceuticals & Drugs industry. The business is part of the broader pharmaceutical value chain and is tracked by investors through Morepen Laboratories Stock Performance, Morepen Laboratories Share Price and Morepen Laboratories Company News. In market terms, it is a Mid Cap company with a market capitalisation of Rs 7,876.83 Cr. Morepen Laboratories Share Price is therefore followed not only for daily moves but also for how the company compares with larger listed pharma peers, its valuation multiples and its return ratios. The business context matters because healthcare investors often compare earnings quality, book value and return measures across the same industry before judging price action.

Track Morepen Laboratories Share Price on Univest

Use Morepen Laboratories (MOREPENLAB) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Investors can track Morepen Laboratories Share Price on Univest for live price updates, fundamental ratios, market capitalisation, 52-week levels and market insights. Morepen Laboratories Share Price, Morepen Laboratories Fundamental Analysis and Morepen Laboratories Stock Analysis are all covered in one place so users can follow the stock alongside broader Healthcare market context.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why did Morepen Laboratories Share Price fall today?

Ans. Morepen Laboratories Share Price fell 5.31% to Rs 139.00 from Rs 146.80. The price move is confirmed in Univest data; a company-specific reason has not been established. The move happened within a live intraday range.

What is the current Morepen Laboratories Share Price?

Ans. Morepen Laboratories Share Price was Rs 139.00 at the latest update. It traded below the previous close of Rs 146.80 and within the day’s range of Rs 138.00 to Rs 148.25, as of 08 October 2026 at 12:23:01 PM IST.

How much did Morepen Laboratories Share Price decline today?

Ans. Morepen Laboratories Share Price declined by Rs 7.80, or 5.31%, from the previous close. The fall is visible in live trade and is significant enough to stand out in Morepen Laboratories Share Price Today coverage.

What is Morepen Laboratories market capitalisation?

Ans. Morepen Laboratories has a market capitalisation of Rs 7,876.83 Cr. Univest data classifies the company as Mid Cap, which provides size context for Morepen Laboratories Share Price and its valuation comparison with healthcare peers.

How does Morepen Laboratories Share Price compare with sector valuation?

Ans. Morepen Laboratories Share Price is backed by a P/E of 57.24 and a P/B of 6.17. Both are above the same-industry median for healthcare, which makes the stock look richer than the broader benchmark set.

What do ROE and ROCE show for Morepen Laboratories?

Ans. Morepen Laboratories reports ROE of 7.96% and ROCE of 10.19%. Both figures sit below the same-industry median, so the return profile is an important part of Morepen Laboratories Fundamental Analysis.

What do EPS and book value mean for Morepen Laboratories Share Price?

Ans. EPS stands at Rs 2.56 and book value is Rs 23.78 per share. EPS shows earnings attributable to each share, while book value shows accounting net worth behind each share, both useful for Morepen Laboratories Share Price analysis.

Is dividend yield important for Morepen Laboratories?

Ans. Morepen Laboratories has a dividend yield of 0.14%. That is a small payout yield relative to the current price, so Morepen Laboratories Share Price is being watched more for valuation and earnings context than for income.

Which peers are useful for Morepen Laboratories Share Price comparison?

Ans. Useful peer references include Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals and Zydus Lifesciences. Their valuation and return ratios help place Morepen Laboratories Share Price within the Pharmaceuticals & Drugs industry.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply